TNFRSF17 and B-cell chronic lymphocytic leukemia: Because soluble BCMA levels are negatively linked with time to treatment failure and OS, but not with the CLL International Prognostic Index, therapeutic methods targeting BCMA may improve the prognosis of CLL patients [132].